YAP1 and chronic kidney disease: The current study focus on the evidence that circRNAs (Circ-YAP1, Circ-APOE & Circ-SLC8A1) and microbiota metabolomics approach detected in different patients of CKD could be of beneficial application in the diagnosis and prognostication of CKD.